Takeabreak2020-08-25 21:55
$万基遗传(MYGN)$ 今年至今跌去30%+的还有$Adma生物制品(ADMA)$, $BioDelivery科学国际(BDSI)$, CRVS查看全文
chuminhua2020-05-23 23:21
5/20,FDA批准了Foundation Medicine和Myriad Genetics$万基遗传(MYGN)$ 的伴随诊断测试,用于AZ和MSD的PARP抑制剂Lynparza(olaparib),用于筛选出适合治疗的转移性去势抵抗性前列腺癌患者。查看全文
网络异常请稍后再试2020-05-12 07:12
$万基遗传(MYGN)$
2019/8/13盘后财报,MISS,8/14号暴跌43%
2019/11/4盘后财报,MISS,11/5号暴跌40%;
2020/2/6盘后财报,MISS,2/7号暴跌30%;
2020/5/5盘后财报,MISS,5/6号跌4%;
这股真是有个性啊。。。。。。查看全文
$万基遗传(MYGN)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-09 AccNo: 0001258897-18-001433 Size: 52 KB 网页链接
$万基遗传(MYGN)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-02-07 AccNo: 0001564590-18-001529 Size: 158 KB 网页链接
$万基遗传(MYGN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-02-07 AccNo: 0001564590-18-001475 Size: 9 MB 网页链接
$万基遗传(MYGN)$ 8-K - Current report Filed: 2018-02-06 AccNo: 0001564590-18-001414 Size: 8 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 美东时间 2018-02-06 盘后 披露财报,预期EPS 0.24 网页链接
$万基遗传(MYGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-26 AccNo: 0001088875-18-000017 Size: 11 KB 网页链接
$万基遗传(MYGN)$ 内部交易: 2018-01-22,E.V.P., General Counsel,MARSH RICHARD M ,卖出,37654普通股, $40.25
$万基遗传(MYGN)$ 内部交易: 2018-01-22,E.V.P., General Counsel,MARSH RICHARD M ,期权,41429普通股, $29.79
$万基遗传(MYGN)$ 内部交易: 2018-01-22,Exec. VP International Ops,King Gary A. ,卖出,34445普通股, $39.67
$万基遗传(MYGN)$ 内部交易: 2018-01-22,Exec. VP International Ops,King Gary A. ,期权,34445普通股, $19.28